Robert K. James 1-440-930-1361 Robert K.

Eastern Time Lisa K. Requests for copies of such Annual Report on Form 10-K or for information on how to obtain directions to be able to attend the Annual Meeting and vote in person should be directed to: PolyOne Center, 33587 Walker Road, Avon Lake, Ohio 44012, Attention: Secretary. Lisa K.

You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. All Rights Reserved 2025 Color, Additives & Inks E N D M A R K E T S R E G I O N S 34% 21% 15% 11% 9% 8% Packaging Telecom 1%Energy 1% Transportation Industrial Consumer 34% 37% 20% 9% US & Canada Latin America Asia Europe, Middle East and Africa Healthcare Building & Construction 21Copyright © . All Rights Reserved 2025 Specialty Engineered Materials E N D M A R K E T S R E G I O N S 20% 17% 14%13% 9% 9% 7% 7% 4% Defense Packaging Telecom Building & construction Transportation Industrial Consumer 54% 33% 13% US & Canada Asia Europe, Middle East and Africa Energy Healthcare Copyright © .

You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. D is t. ) K W R P P G F U L R P M A V Y F M C H U N H X L S C L E C L E M N C E A S H Source: Peer data per Bloomberg market data as of February 15, 2022. O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 5.4 8.5 10.1 10.0 15.7 15.0 14.2 12.7 10.2 25.0 19.7 17.7 13.2 12.3 10.0 9.9 8.9 8.5 8.3 6.6 A vi e n t (2 0 1 1 ) A vi e n t (2 0 1 6 ) A vi e n t (2 0 2 1 ) A vi e n t (T o d a y) R P M K W R P P G A V Y F U L A L B E C L H X L A S H F M C B N R E M N U N V R C E S C L H U N Historic Multiple S U M M A RY: W H Y I N V E S T I N AV I E N T ?

Discuss with management and the independent auditor the financial information to be included in the Company’s Annual Report on Form 10-K, including the annual audited financial statements and the Company’s disclosures in “Management’s Discussion and Analysis of Financial Condition and Results of Operations”. 2. Review and approve all related-party transactions, defined as those transactions required to be disclosed under Item 404 of Regulation S-K. 9. Recommend to the Board whether the financial statements should be included in the Annual Report on Form 10-K. 12.

You are advised, however, to consult any further disclosures we make on related subjects in our reports on Forms 10-Q, 8-K and 10-K furnished to the SEC. I have reviewed this Annual Report on Form 10-K of PolyOne Corporation; 2. I have reviewed this Annual Report on Form 10-K of PolyOne Corporation; 2.

Garratt, Senior Vice President, Chief Commercial Officer Lisa K. Lisa K. a) Section 3 (b) Section 22 (c) Section 4(d)( ) (d) (e) (f) (g) (h) (i) Section 5 (j) (k) (l) (m) 5.

K” is the proportionality constant, which can be determined from figure 13. FIGURE 11 - Non-Structural Hole Design Guidelines B = 2W = 2W = 2W FIGURE 12 - Non-structural hole design guidelines FIGURE 13 - Snap Fit Design Guidelines Y 1 y= ε=l2 1.5t1 1 y= ε=l2 K 1.5t12 “K” is found from graph based on t 2 /t 1 . For t 2 /t 1 = 1, K = 1.

You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. D is t. ) K W R P P G A V Y F U L R P M G C P F M C H X L H U N E C L A S H E M N C E S C L Source: Peer data per Bloomberg market data as of November 8, 2021 Avient reflects 2021 estimated revenue of $4,750M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. With the Clariant Color business acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 33 Avient reflects 2021 estimated EBITDA of $580M O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 11.4 20.2 16.7 16.5 14.7 12.0 10.8 40.7 29.9 26.2 13.2 12.4 11.0 10.9 9.1 9.0 7.5 6.5 A vi e n t K W R P P G A V Y R P M F U L G C P A L B H X L E C L A S H F M C B N R S C L U N V R E M N C E H U N S U M M A RY: W H Y I N V E S T I N AV I E N T ?

Polymer Diagnostics Inc. 33587 Walker Road Avon Lake, Ohio 44012 United States +1 800 438 2335 +1 440 930 1644 fax Polymer Diagnostics Inc. is a contract laboratory with accreditation to ISO/IEC 17025 by the American Association for Laboratory Accreditation (A2LA) for both chemical and mechanical capacities. 1 7 . 2 8 . 2 5 i n 8 . 5 i n 1 7 C M Y K HC_Industry bulletin_PDI_fi nal.indd REMAY 78810 TR: 16.5000" x 11.6875" and 17.000" x 11.000" Digital/IAM BL: 17.2500" x 11.9375" FINAL: 8.2500" x 11.6875" and 8.500" x 11.000" 11 .6 8 7 5 in 2 5 i n 11 .9 3 7 5 in 8 . 2 5 i n 8 . 5 i n 11 in i n Asset No. 78810 Polymer Diagnostics Inc. PDI has extensive experience with the testing of medical devices and materials including: • Catheters • Bio-implants • Surgical diagnostic devices • Medical tubing • Other disposable medical devices Issues often arise as a result of: • Improper design or choice of material • The environment of exposure • Processing conditions World-class people and capabilities under one roof • Failure Analysis/Prevention • Qualifi cation Support • Rheology • Polymer Characterization • Deformulation • Physical Testing • Litigation Support • Characterization of polymers in pharmaceutical delivery systems • Phthalate and BPA testing 1 7 . 2 8 . 2 5 i n 8 . 5 i n 1 7 C M Y K HC_Industry bulletin_PDI_fi nal.indd REMAY 78810 TR: 16.5000" x 11.6875" and 17.000" x 11.000" Digital/IAM BL: 17.2500" x 11.9375" FINAL: 8.2500" x 11.6875" and 8.500" x 11.000" 11 .6 8 7 5 in 2 5 i n 11 .9 3 7 5 in 8 . 2 5 i n 8 . 5 i n 11 in i n Asset No. 78810 Polymer Diagnostics Inc. Polymer Diagnostics Inc. 33587 Walker Road Avon Lake, Ohio 44012 United States +1 800 438 2335 +1 440 930 1644 fax Polymer Diagnostics Inc. is a contract laboratory with accreditation to ISO/IEC 17025 by the American Association for Laboratory Accreditation (A2LA) for both chemical and mechanical capacities. 1 7 . 2 8 . 2 5 i n 8 . 5 i n 1 7 C M Y K HC_Industry bulletin_PDI_fi nal.indd REMAY 78810 TR: 16.5000" x 11.6875" and 17.000" x 11.000" Digital/IAM BL: 17.2500" x 11.9375" FINAL: 8.2500" x 11.6875" and 8.500" x 11.000" 11 .6 8 7 5 in 2 5 i n 11 .9 3 7 5 in 8 . 2 5 i n 8 . 5 i n 11 in i n Asset No. 78810